Juan Quevedo
London, ENG EC2M1QS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CEFEPIME/ENMETAZOBACTAM: Physicochemical Stability of a Novel β-Lactam/β-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices.
Journal: Antibiotics (Basel, Switzerland)
Published: December 26, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales.
Journal: Future microbiology
Published: February 26, 2025
'In vitro activity of cefepime-enmetazobactam on carbapenem-resistant gram negatives'-author's response.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 18, 2025
Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis.
Journal: Journal of comparative effectiveness research
Published: January 16, 2025
In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing Klebsiella pneumoniae.
Journal: Microbiology spectrum
Published: October 31, 2024
In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 15, 2024
Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates.
Journal: Journal of global antimicrobial resistance
Published: December 13, 2023
In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016-19).
Journal: JAC-antimicrobial resistance
Published: October 27, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026